Flagship Harbor Advisors’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $542K | Buy |
2,280
+27
| +1% | +$5.61K | 0.02% | 499 |
|
|
2026
Q1 | $476K | Buy |
2,253
+1
| +0% | +$215 | 0.02% | 484 |
|
|
2025
Q4 | $463K | Sell |
2,252
-2,508
| -53% | -$472K | 0.02% | 461 |
|
|
2025
Q3 | $747K | Buy |
4,760
+204
| +4% | +$31.5K | 0.03% | 389 |
|
|
2025
Q2 | $765K | Buy |
4,556
+59
| +1% | +$8.76K | 0.04% | 367 |
|
|
2025
Q1 | $620K | Sell |
4,497
-24
| -0.5% | -$3.06K | 0.03% | 380 |
|
|
2024
Q4 | $535K | Buy |
4,521
+295
| +7% | +$34.4K | 0.03% | 408 |
|
|
2024
Q3 | $467K | Buy |
4,226
+283
| +7% | +$29.6K | 0.03% | 433 |
|
|
2024
Q2 | $388K | Sell |
3,943
-1,045
| -21% | -$106K | 0.02% | 471 |
|
|
2024
Q1 | $558K | Buy |
4,988
+1,677
| +51% | +$181K | 0.04% | 360 |
|
|
2023
Q4 | $334K | Sell |
3,311
-2,255
| -41% | -$224K | 0.02% | 463 |
|
|
2023
Q3 | $483K | Buy |
5,566
+453
| +9% | +$41K | 0.04% | 339 |
|
|
2023
Q2 | $484K | Buy |
5,113
+357
| +8% | +$30.2K | 0.04% | 344 |
|
|
2023
Q1 | $359K | Buy |
4,756
+20
| +0.4% | +$1.51K | 0.03% | 435 |
|
|
2022
Q4 | $364K | Sell |
4,736
-234
| -5% | -$17.8K | 0.04% | 412 |
|
|
2022
Q3 | $331K | Buy |
4,970
+5
| +0.1% | +$317 | 0.04% | 412 |
|
|
2022
Q2 | $260K | Sell |
4,965
-100
| -2% | -$5.68K | 0.03% | 495 |
|
|
2022
Q1 | $287K | Sell |
5,065
-440
| -8% | -$23.6K | 0.03% | 495 |
|
|
2021
Q4 | $283K | Sell |
5,505
-251
| -4% | -$12.3K | 0.03% | 511 |
|
|
2021
Q3 | $329K | Hold |
5,756
| – | – | 0.04% | 458 |
|
|
2021
Q2 | $329K | Buy |
5,756
+512
| +10% | +$29.9K | 0.04% | 459 |
|
|
2021
Q1 | $319K | Sell |
5,244
-464
| -8% | -$25.6K | 0.04% | 460 |
|
|
2020
Q4 | $306K | Sell |
5,708
-838
| -13% | -$43.5K | 0.04% | 422 |
|
|
2020
Q3 | $307K | Buy |
6,546
+1,505
| +30% | +$77.2K | 0.04% | 361 |
|
|
2020
Q2 | $263K | Buy |
5,041
+85
| +2% | +$4.38K | 0.04% | 390 |
|
|
2020
Q1 | $238K | Sell |
4,956
-268
| -5% | -$13.9K | 0.05% | 348 |
|
|
2019
Q4 | $264K | Sell |
5,224
-75
| -1% | -$3.87K | 0.05% | 374 |
|
|
2019
Q3 | $250K | Buy |
5,299
+1,076
| +25% | +$49.1K | 0.05% | 359 |
|
|
2019
Q2 | $198K | Buy |
4,223
+1,784
| +73% | +$82.3K | 0.04% | 396 |
|
|
2019
Q1 | $117K | Buy |
2,439
+102
| +4% | +$5.11K | 0.02% | 521 |
|
|
2018
Q4 | $104K | Sell |
2,337
-1,189
| -34% | -$62K | 0.03% | 501 |
|
|
2018
Q3 | $190K | Buy |
3,526
+2,716
| +335% | +$139K | 0.04% | 428 |
|
|
2018
Q2 | $39K | Buy |
+810
| New | +$45.9K | 0.01% | 866 |
|
Other funds holding CAH
Flagship Harbor Advisors's CAH Position: Q2 2026 in Review
Flagship Harbor Advisors increased its Cardinal Health (CAH) stake by 1.2% in Q2 2026, buying an estimated $5.61K and bringing the position to 2,280 shares worth $542K. The position accounts for 0.02% of the portfolio, ranked #499.
Flagship Harbor Advisors first reported a position in CAH in Q2 2018 and has held it in 33 quarters since. The position peaked at $765K in Q2 2025. 1,500 funds tracked by Wall St. Rank hold CAH as of Q2 2026.
- Flagship Harbor Advisors held 2,280 shares of Cardinal Health worth $542K as of Q2 2026.
- Flagship Harbor Advisors bought 27 Cardinal Health shares in Q2 2026, an estimated $5.61K.
- Cardinal Health made up 0.02% of Flagship Harbor Advisors's portfolio in Q2 2026, its #499 holding.
- Flagship Harbor Advisors first reported a position in Cardinal Health in Q2 2018 and has held it in 33 quarters since.
- Flagship Harbor Advisors's Cardinal Health position peaked at $765K in Q2 2025.
- 1,500 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.
Based on Flagship Harbor Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.